All In Biotech

Drug Trial Radar · NCT02715115

A Safety Study of NNZ-2566 in Pediatric Rett Syndrome

A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome

Last checked: Nov 19, 2026Latest source record: Aug 14, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

82

Actual

Start

Mar 2016

Primary completion

Jan 5, 2017

Study completion Jan 5, 2017

Sponsor

Lead sponsor
Neuren Pharmaceuticals LimitedIndustry
Sponsor type
Industry
Collaborators
rettsyndrome.org
First posted
Mar 22, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 5 years, up to 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether NNZ-2566 is safe and well tolerated in the treatment of Rett syndrome in children and adolescents.

Conditions

  • Rett Syndrome

Interventions

  • NNZ-2566Drug

    Glycyl-L-2-Methylpropyl-L-Glutamic Acid (NNZ-2566) supplied as a lyophilized powder for reconstitution with strawberry flavored solution 0.5% v/v in Water for Injection.

  • PlaceboDrug

    Strawberry flavored solution and Water for Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse eventsTime frame: Through study completion, an average of 11 weeks

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama

    Birmingham, Alabama

  • UCSF Benioff Children's Hospital Oakland

    Oakland, California

  • University of California, San Diego

    San Diego, California

  • Children's Hosptial Colorado

    Aurora, Colorado

  • Rush University Medical Center

    Chicago, Illinois

  • Boston Children's Hospital

    Boston, Massachusetts

  • Gillette Children's Specialty Healthcare

    Saint Paul, Minnesota

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • Greenwood Genetic Center

    Greenwood, South Carolina

  • Vanderbilt University

    Nashville, Tennessee

  • Baylor College of Medicine

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.